Invesco Biotechnology & Genome ETF
PBE
#1964
ETF Rang
€0.38 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
87,98 €
Aktienkurs
-0.87%
Veränderung (1 Tag)
40.45%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 20. Oktober 2026Anzahl der Bestände: 33

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
5.99%
Natera IncNTRA63598
5.91%
Illumina IncILMN95180
5.47%
Biogen IncBIIB96999
5.22%
Gilead Sciences IncGILD143942
4.98%
Royalty Pharma PLCRPRX345003
4.93%
Amgen IncAMGN48422
4.81%
Regeneron Pharmaceuticals IncREGN25690
4.62%
Vertex Pharmaceuticals IncVRTX38735
4.13%
Moderna IncMRNA73546
3.28%
Novavax IncNVAX1237348
3.08%
Halozyme Therapeutics IncHALO106848
3.07%
Exelixis IncEXEL205933
3.03%
QIAGEN NVQGEN267595.3786
2.89%
United Therapeutics CorpUTHR22527
2.75%
Veracyte IncVCYT265226
2.74%
Sarepta Therapeutics IncSRPT617365
2.67%
Repligen CorpRGEN64289
2.66%
TG Therapeutics IncTGTX210764
2.54%
Vericel CorpVCEL270258
2.51%
Neurocrine Biosciences IncNBIX76161
2.48%
Protagonist Therapeutics IncPTGX77565
2.43%
Incyte CorpINCY90045
2.42%
Legend Biotech CorpLEGN548382
2.32%
PTC Therapeutics IncPTCT158985
2.31%
BioMarin Pharmaceutical IncBMRN176657
2.30%
Ardelyx IncARDX3090096
2.29%
Collegium Pharmaceutical IncCOLL425211
2.19%
BioCryst Pharmaceuticals IncBCRX1188257
2.11%
AnaptysBio IncANAB200112
1.81%
ACADIA Pharmaceuticals IncACAD382093
0.04%
Invesco Government & Agency PortfolioAGPXX181944.51
0.00%
CASH & EQUIVALENTSUSD5728
0.00%
USD Pending DividendsUSDPDV0